Keywords: impact, generics, usa, overview, merrill, lynch, pharmaceutical

The impact of generics in the USA: an overview from Merrill Lynch

Article | 19 May 2003

Print This

Pharmaceutical manufacturers in the USA face two major challenges: a wave of major product patent expirations in 2006/7 and litigation that ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in